For Providers

Allergy Therapy Despite Busy Schedules

"Allergychoices has really made it possible for many of our patients to get allergy therapy when they just wouldn't have had the time and ability to do it."

Provider review

Watch the review

Reviewed by

— Matthew Patterson, MD, ENT | MN

In their own words

“The response from patients has been fantastic. It’s convenient for families. Parents with children who need therapy who are in school are able to have the therapy at home instead of having to come in weekly for the injection therapy.

“Allergychoices has allowed us to offer our patients another alternative which enables them to free up their schedule. It’s difficult for patients with families and many other commitments, time constraints make it very difficult. Allergychoices has really made it possible for many of our patients to get allergy therapy when they just wouldn’t have had the time and ability to do it.”

Keep watching

More provider reviews

Next step

Tired of seeing your allergy patients suffer?

Call us at (866) 793-1680 or fill out this form to discuss offering this safe and effective option!

Regulatory status of allergy drops

A small number of sublingual immunotherapy (SLIT) tablets are FDA-approved for specific allergens. Personalized allergy drops are compounded by a pharmacy for each patient and prescribed off-label — a long-standing, legitimate practice with decades of use, and SLIT is a first-line prescription approach in much of Europe. Compounded allergy drops are not FDA-approved, but they are created using FDA-approved allergenic extracts, the same as in allergy shots. Off-label does not mean unsafe or experimental.

U.S. allergenic extracts are licensed and labeled for injection and skin testing, not for the sublingual route, so prescribing them as sublingual drops is an off-label clinical decision made by the treating provider.